Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.
about
ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control studyDiscovery and validation of breast cancer early detection biomarkers in preclinical samplesPlasma protein characteristics of long-term hemodialysis survivorsApplication of proteomics to cancer early detectionTIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.TraceRNA: a web application for competing endogenous RNA explorationA bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.An ultrasensitive electrochemiluminescence immunoassay for carbohydrate antigen 19-9 in serum based on antibody labeled Fe3O4 nanoparticles as capture probes and graphene/CdTe quantum dot bionanoconjugates as signal amplifiers.Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.Noninvasive strategies for breast cancer early detection.Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer
P2860
Q33772914-56588C36-57D4-42F8-BF3A-362F42D61FE7Q33790538-6575BF0C-AF50-41C3-B48E-DB3200BE262AQ33907528-44F2E328-7A9E-4977-B988-258907C85805Q34003835-386FC360-6141-422F-86FC-92692FBB34B1Q34200678-41735056-F894-41B6-8DE6-DBEE6930DA24Q34336049-D162E8DD-ED95-4E8A-9324-0C8BC57D9E81Q35053031-3584BA37-19F8-401C-9B00-D58157D377DFQ35665493-24579547-6908-4E4B-9D7D-054D7293BC87Q35911749-927BBF5D-CABC-456A-BD75-36CEE0948FEBQ36028777-2B5E8DEB-6328-45CA-B45C-011E683DC863Q36396615-87386AEF-FCC0-4B5F-9C92-71A997F4CF88Q36487046-FF58939D-5339-45F7-B3D9-7EE20C8C225CQ36913756-03143F49-A784-4036-9463-220F740DB3D0Q38665032-DBE4FB29-3932-45F0-86F3-06D413B5DDBBQ38753775-55BBB50D-5561-49DD-92E8-E4680449836FQ38885953-FBB59A82-2078-415C-9750-465BFB47B26CQ42682509-87541B80-8732-4B58-986F-D951E4FB6268
P2860
Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Detection of elevated plasma l ...... s among hormone therapy users.
@ast
Detection of elevated plasma l ...... s among hormone therapy users.
@en
type
label
Detection of elevated plasma l ...... s among hormone therapy users.
@ast
Detection of elevated plasma l ...... s among hormone therapy users.
@en
prefLabel
Detection of elevated plasma l ...... s among hormone therapy users.
@ast
Detection of elevated plasma l ...... s among hormone therapy users.
@en
P2093
P2860
P1433
P1476
Detection of elevated plasma l ...... s among hormone therapy users.
@en
P2093
Alice Chin
Chee-Hong Wong
Christopher I Li
Jacob Kennedy
Lynn M Amon
Martin W McIntosh
Melissa M Johnson
Paul D Lampe
Qing Zhang
P2860
P304
P356
10.1158/0008-5472.CAN-10-1676
P407
P577
2010-10-19T00:00:00Z